<http://webisa.webdatacommons.org/62258650>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/62258650>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<cancer.gov> .
<http://webisa.webdatacommons.org/prov/144026482>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/62258650> .
<http://webisa.webdatacommons.org/prov/254180420>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/62258650> .
<http://webisa.webdatacommons.org/62258650>	<http://www.w3.org/ns/prov#value>	"ring a press briefing, with therapy decisions guided by factors such as comorbidities and patient preference, among others.The results of the trial were published online August 9, 2011, in The Lancet (see the journal abstract)." .